Log in to save to my catalogue

Hyperactive mTORCI in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular re...

Hyperactive mTORCI in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular re...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracgeneralonefile_A786063952

Hyperactive mTORCI in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodeling

About this item

Full title

Hyperactive mTORCI in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodeling

Publisher

American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2024-02, Vol.134 (4)

Language

English

Formats

Publication information

Publisher

American Society for Clinical Investigation

More information

Scope and Contents

Contents

Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease caused by tuberous sclerosis complex 1/2 (TSC1/2) gene mutations in pulmonary mesenchymal cells, resulting in activation of the mechanistic target of rapamycin complex 1 (mTORC1). A subset of patients with LAM develop pulmonary vascular remodeling and pulmonary hypertension. Little...

Alternative Titles

Full title

Hyperactive mTORCI in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodeling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracgeneralonefile_A786063952

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracgeneralonefile_A786063952

Other Identifiers

ISSN

0021-9738

DOI

10.1172/JCI172116

How to access this item